{"a":[{"_":"Cellares links with GenomeFrontier to test automation approach for virus-free CAR-Ts","$":{"href":"/manufacturing/cellares-links-genomefrontier-evaluate-virus-free-car-t-therapy-production","hreflang":"en"}}]}

Summary

Cellares partnered with GenomeFrontier Therapeutics to evaluate the use of Cellares' cell shuttle platform for production of virus-free CAR-T therapies. The collaboration aims to test automation approaches in cell therapy manufacturing.